Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A)

Class:IdLiteratureReference:9975359
_displayNameDifferent transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A)
_timestamp2025-12-01 09:43:28
author[Person:9794638] Motohashi, Hideyuki
[Person:9973764] Uwai, Yuichi
[Person:9692947] Hiramoto, Kiyo
[Person:5336448] Okuda, Masahiro
[Person:3165228] Inui, Ken-Ichi
created[InstanceEdit:9975379] Stephan, Ralf, 2025-12-01
journalEur J Pharmacol
pages25-30
pubMedIdentifier15496291
titleDifferent transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A)
volume503
year2004
(literatureReference)[Reaction:9975267] OAT3 transports xenobiotics with antiport of dicarboxylate [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A) (9975359)